Skin Cancer/Melanoma

Exposure to certain high blood pressure drugs, specifically thiazide diuretics, may increase a person’s risk of developing skin cancer.

The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.

Skin cancer rates have been increasing worldwide, and climate change factors – like depleting ozone layers – may be a factor.

From Dick Vitale’s early melanoma cancer detection to the authorization of COVID-19 vaccine booster shots for patients with cancer, here’s what’s happening in the cancer landscape this week.

The bacteria in a patient’s gut could be linked to side effects from combined checkpoint inhibitors in patients with melanoma.

Here are five options for overcoming stress and anxiety to promote your mental wellness and emotional resilience during your radiation therapy.

Vitamin D is essential for strong bones and a healthy immune system. While a limited amount of the vitamin can be obtained from exposure to the sun’s ultraviolet (UV) radiation, the suggestion that the best way to obtain vitamin D is through sun exposure is both misleading and dangerous.

What you should know about UV manicures and cancer risk.

“There is every reason sunscreen can be promoted on what it does in its ability to reduce your risk of skin cancers over its cosmetic application to prevent the signs of aging,” writes a melanoma survivor.

CURE® offers tips to stay relaxed and healthy during the summer months.

An expert from The Skin Cancer Foundation explained how to read sunscreen labels, sun safety practices, common misconceptions about skin cancer and what cancer survivors should know about their risk.

In its Speaking Out video series, on behalf of Aim at Melanoma, CURE ® spoke with Dr. Sunandana Chandra about emerging therapies in melanoma.

Several sunscreens packaged with aerosol were found to contain benzene, which has been associated with risk of leukemia.

One expert talks the benefits of excising in surgical management, as well as what to expect after.

Skin cancer can have detrimental effects on not only a patient’s physical health, but their emotional and mental health as well, according to an expert at the CURE® Educated Patient® Skin Cancer Summit.

On behalf of AiM at Melanoma, Drs. Jeffrey Farma and Sunandana Chandra discuss current and future treatment options for melanoma, including a rare subtype.

Patients with skin cancer who are treated with radiation therapy as an alternative to surgery tend to experience effective results thanks to advanced technologies, according to an expert at the CURE® Educated Patient® Skin Cancer Summit.

Patients with melanoma are living longer than ever before and some, according to an expert from the Rutgers Cancer Institute of New Jersey, are even getting cured or achieving long-term remissions thanks to developments in the treatment landscape.

Topical treatments may lead to little to no scarring in patients with surface-level skin cancer, but patient characteristics, time of year, tumor characteristics and cost determine course of action.

Anna C. Pavlick, D.O., describes the various challenges health care providers may face when treating patients with locally advanced basal cell carcinoma (laBCC).

Insights into cemiplimab treatment monitoring and management in locally advanced basal cell carcinoma (laBCC).

An expert discusses treatment options available for patients with locally advanced basal cell carcinoma (laBCC) who don’t respond or are intolerant to the first-line therapy option.

The Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) for the treatment of patients with locally advanced cutaneous squamous cell carcinoma (cSCC) that cannot be cured by surgery or radiation.

As rates of merkel cell carcinoma increase, patients should be aware of the risk factors and symptoms of this skin cancer.

After a previous diagnosis of skin cancer, patients are more likely to develop skin cancer lesions on the body. An expert gives helpful tips on what to look for and how to look for lesions to catch them early.

Patients with basal cell or cutaneous squamous cell carcinoma tend to have good outcomes when the disease is caught early. For those in later stages, new treatments bring hope and better prognoses.

Anna C. Pavlick, DO, provides an overview of hedgehog inhibitors, a first-line treatment option for patients diagnosed with locally advanced basal cell carcinoma (laBCC).

A discussion about multidisciplinary management of locally advanced basal cell carcinoma (laBCC) and how dermatologists and medical oncologists collaborate within the care of a patient.

An expert discusses features of a skin lesion that would prompt a skin biopsy in the diagnosis of locally advanced basal cell carcinoma (laBCC).

Anna C. Pavlick, D.O., provides an overview of locally advanced basal cell carcinoma (laBCC) that includes the different risk factors and clinical presentations.